Debra Ritzwoller to Treatment Outcome
This is a "connection" page, showing publications Debra Ritzwoller has written about Treatment Outcome.
Connection Strength
0.485
-
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
Score: 0.097
-
Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
Score: 0.086
-
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
Score: 0.080
-
Twelve-month outcomes of an Internet-based diabetes self-management support program. Patient Educ Couns. 2012 Apr; 87(1):81-92.
Score: 0.075
-
Outcomes of minimal and moderate support versions of an internet-based diabetes self-management support program. J Gen Intern Med. 2010 Dec; 25(12):1315-22.
Score: 0.069
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.027
-
Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med. 2012 Apr 09; 172(7):565-74.
Score: 0.019
-
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
Score: 0.019
-
Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care. 2005 Jun; 43(6):551-7.
Score: 0.012